Organisers Closer Still Media have published details of the small animal clinical sessions being held in the RVC Clinical Theatres 1, 2 and 3, and BVA’s farm theatre and equine stream (in partnership with BEVA).
Charlotte Ellicott, Head of Marketing and Content, said: “The clinical streams are shaping up to be cutting-edge this year.
"We are delighted to have the continued support of excellent CPD providers like the RVC and BVA.
"Later in the year we will also be able to supplement these key theatres with the line-ups from IDEXX’s Advanced Diagnostic Stream, IVC Evidensia’s Referral Theatre, Central CPD’s Wet Labs and many more.”
Professor Jill Maddison, Professor of General Practice at the RVC said: "We have a fantastic line-up of speakers gathering from near and far who will be delivering lectures covering all aspect of clinical practice.
"Our keynote international speaker will be Caroline Mansfield, Professional Research Fellow and Registered Specialist in Small Animal Medicine, who will be presenting six sessions covering all things gastroenterology."
British Veterinary Association President Malcolm Morley said: “This really is a remarkable programme and I would encourage all vets to take advantage of the high-quality CPD opportunities on offer at London Vet Show this year.
"We look forward to complementing these excellent clinical sessions with another round of thought-provoking BVA Congress discussions. The topics for these will be announced soon.”
Early bird tickets for the London Vet Show are on sale until 28th April for £289+VAT.
BVA and BEVA members receive further discounts.
London.vetshow.com.
However, when asked by VetSurgeon.org which audience - veterinary professionals, it's staff or the public - it was referring to, or what threats to safety and wellbeing were posed by X, the College refused point blank to answer.
So the real motivation remains unclear.
On the one hand, it could be a ridiculously over-sensitive move to protect its unknown audience from opinions that its staff find objectionable.
On the other hand, it could perfectly well be argued that short form social media reduces every discussion or debate to "I'm effing right and you're effing wrong", which is not appropriate for a scientific profession.
Equally, one could also argue that engaging in polarised debate online is not terribly good for one's wellbeing.
Or one could just argue that it's a terrible platform owned by a strangely meddlesome and interfering American.
However, given the College's strange refusal to expand on the reasons for its withdrawal, the first explanation seems more likely.
But who knows?
https://www.rcvs.org.uk/news-and-views/news/rcvs-statement-on-x-formerly-twitter/
BVA Scottish Branch President Grace Webster said: "We commend the Scottish Government on seizing the opportunity to improve animal welfare through the introduction of a Bill to ban of the use of wild animals in travelling circuses. While the use of wild animals in travelling circuses may not affect a great number of individual animals, it is emblematic of the way we treat all animals and we would urge the rest of the UK to follow this precedent, introduced on ethical grounds.
"However, this package of measures seems a bit of a mixed bag. Until recently Scotland also led the way on dog welfare with a complete ban on tail docking, so we are extremely disappointed at the decision to reverse this stance. We have carefully considered all the evidence and remain convinced that tail docking in dogs, even specific breeds, is detrimental to their welfare. This is a retrograde step for animal welfare in Scotland, amidst an otherwise progressive package of animal welfare measures."
At the end of May, BVA Scottish Branch Junior Vice President Melissa Donald will be giving evidence to the Environment Committee in the Scottish Parliament ahead of a vote on whether or not to approve the change in law relating to tail docking.
Today’s announcement by the Cabinet Secretary for Environment, Climate Change and Land Reform Roseanna Cunningham MSP also included the introduction of controls to restrict the use of electronic training collars and a commitment to update regulations to combat the irresponsible breeding and sale of dogs, cats and rabbits.
Gudrun Ravetz, BVA President, added: "Animal welfare starts right at the beginning of a pet’s life, so the focus on pet licensing and breeding regulations is welcome. We know that a third of vets are seeing puppies they believe to have been illegally imported and an increasing number of owners are buying brachycephalic or designer breeds, like Scottish fold cats; pets must be purchased with owners prioritising animal health and welfare, rather than making an impulse buy based on looks alone.
"Yet we are saddened at the shortfall on legislation around aversive training aids for dogs, which we expect will still permit the use of training collars under expert guidance. We know using fear as a training tool is not only less effective than positive reinforcement, but can take its toll on a dog’s overall welfare. Without an outright ban, we have grave concerns over how enforceability will work. This raft of measures seems to give with one hand and take away with the other."
The Vet Wellbeing Awards, which are now in their fourth year, are designed to highlight positivity within the profession by sharing stories and initiatives from veterinary workplaces that demonstrate commitment to improving staff wellbeing.
The Awards also aim to support all practices to take a structured approach towards evaluating their own wellbeing support systems.
This year, for the first time, feedback will be given to practices that enter about the areas where they are doing well and those where they can improve. The organisers hope that this change to the Awards process will encourage practices to think of wellbeing support as an area of continuous development.
However, they also hope that practices will use the entry process as an opportunity to audit wellbeing even if they don't plan to enter.
Liz Barton, SPVS Board Member, said: "Going through the entry form and evaluation process is valuable for every vet practice, even if they don’t feel they’re ready to enter the Awards just yet. Sitting down as a practice team for a few hours and working through the questionnaire is a highly useful exercise for facilitating celebrating areas where your practice is doing well for wellbeing, and also highlighting some areas for improvement for years to come."
"We recommend all practices get into the habit of going through the process annually and choosing areas to focus and improve on, to build towards better wellbeing across all areas for all staff."
There are three award categories that practices can enter depending on the number of employees: small practice (15 or fewer full time equivalent team members (FTE)), medium practice (16 to 50 FTEs) or large practice (51 or FTEs).
The Award application form covers six aspects of work that, if well-managed, can promote wellbeing and reduce the risk of work-related stress, and the Award judges will be looking for evidence of commitment to enhancing wellbeing for each of these.
They are:
Promoting physical and psychological health at work
Relationships at work
Communication at work
Career development
Workload and work scheduling
Work demands
More examples of the type of evidence and initiatives that the Awards are looking for, together with the entry form, are available on the Vet Wellbeing Awards website: https://vetwellbeingawards.org.uk.
Winning and Highly Commended practices will receive a dedicated logo and certificate for display. The winners in each category will also receive two registrations and banquet tickets for SPVS/VMG Congress 2020.
In addition to the Wellbeing Awards, the RCVS and SPVS are also running the Practice Star nominations, which are open to all veterinary practices.
These nominations aim to support practices to thank someone in their team who has gone the extra mile to make the practice a happy place to work, whether this be through introducing an initiative that makes everyone’s work life better, going out of their way to support a colleague going through a tough time, or just making everyone smile.
To enter, practices need to send in their nominee’s name, job title and contact details, and a short paragraph explaining why they have been chosen. They will then receive a certificate congratulating them for being nominated as the practice’s very own ‘Practice Wellbeing Star’.
The closing date for both the Wellbeing Award entries and Practice Star nominations is Friday 22 November 2019.
The study, which was led by Robert Hyde MRCVS from the School of Veterinary Medicine and Science at the University of Nottingham, aims to create an automated diagnostic support tool for the diagnosis of herd level mastitis origin, an essential first step of the AHDB mastitis control plan.
Mastitis data from 1,000 herds’ was inputted for several three-month periods. Machine learning algorithms were used to classify herd mastitis origin and compared with expert diagnosis by a specialist vet.
The machine learning algorithms were able to achieve a classification accuracy of 98% for environmental vs contagious mastitis, and 78% accuracy was achieved for the classification of lactation vs dry period environmental mastitis when compared with expert veterinary diagnosis.
Robert said: “Mastitis is a huge problem for dairy farmers, both economically and in welfare terms. In our study we have shown that machine learning algorithms can accurately diagnose the origin of this condition on dairy farms. A diagnostic tool of this kind has great potential in the industry to tackle this condition and to assist veterinary clinicians in making a rapid diagnosis of mastitis origin at herd level in order to promptly implement control measures for an extremely damaging disease in terms of animal health, productivity, welfare and antimicrobial use."
Reference
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
Dechra Veterinary Products has launched a new 50 ml bottle of its rapid acting dissociative anaesthetic licensed for cats, dogs and horses, Anesketin.
Anesketin solution for injection, containing Ketamine 100 mg/ml, is indicated for induction of anaesthesia.
Dechra Brand Manager Craig Sankey said: "Anesketin has proved to be a very popular product in our range due to its versatility. It can be used in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction of anaesthesia.
"As it does not require any special temperature storage conditions it makes it a very portable product for vets on the move."
He added: "We are very pleased to be able to add the larger Anesketin product to our wide range of analgesics and sedatives. This demonstrates our commitment to offering high quality products that support vets in small animal and equine practice."
Dechra says the product can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in cats.
Anesketin is also available in 10 ml vials. For further information, visit www.dechra.co.uk
The group is hoping to raise more than £5,000 for the hospital by donating £1 for every pet vaccinated at its West Derby, Gateacre, St Helens and Widnes practices over the next four months.
Sarah Kirkman MRCVS, from White Cross Vets in Gateacre, said: "It’s our job to care for pets, but we also really care about the communities in which we operate, and we have a real affinity with the hospital. This partnership means we’re protecting pets, by vaccinating them against a wide range of nasty diseases, as well as raising money to support the invaluable work that the hospital does."
Allan Eves from Alder Hey Children’s Charity said: "We care for over 275,000 children, young people and their families treating everything from common illnesses to highly complex and specialist conditions. We also lead research into children’s medicines, infection, inflammation and oncology and our charity has raised over £22m to support Alder Hey Children’s Hospital, funding life-saving medical equipment, research and vital facilities. We are so pleased to be working with White Cross Vets on this superb fund-raising initiative and can’t wait to meet the vets and nurses who are helping us."
Sarah added: "We are aiming to raise £5,000, but it could be more. We also want to support the hospital’s therapy dog by providing them with our Complete Wellness Plan for free. The plan provides free health-checks, veterinary care and preventative treatment on an ongoing basis. We already give free membership to several Fire Service Search Dog Teams, as we feel it’s really important to look after these amazing dogs which dedicate their lives to help people."
The charitable campaign is running from the 4th September until the 31st December and plans are also in place for the veterinary surgeons and nurses from White Cross Vets to visit the hospital regularly to talk to the children about pets.
Sarah said: "We give every one of our team four paid donation days a year, so that they can volunteer with a charity of their choice, and we are keen to further our partnership with the hospital by visiting regularly. We already do this in numerous schools across the region and know just how much children love to find out about our day to day roles, and they always have plenty of interesting questions for our nurses and vets to answer."
Burgess reminds everyone that RVHD2 is a highly infectious strain of RVHD with few or no visible symptoms. It is fatal and can kill within hours. RVHD2 poses a significant threat to Britain’s rabbit population and outbreaks have been reported all over the UK and Ireland meaning no area is safe.
According to the company, the most recent sales figures show that only 137,405 RVHD2 vaccinations have been distributed in the last year1. This, says the company, shows a concerning number of practices are still not stocking the necessary vaccines to protect rabbits against RVHD2 and other fatal diseases.
Rabbits who have received the combined vaccination for RVHD and myxomatosis need a separate vaccination for RVHD2.
BSAVA President Sue Paterson said: "The British Small Animal Veterinary Association (BSAVA) supports the Rabbit Awareness Week 'Protect and Prevent' approach to saving the lives of rabbits in the UK. The BSAVA urges all rabbit owners to get their rabbits vaccinated against this disease and encourages all practices to remind their clients of the importance of doing this."
Richard Saunders BVSc DZooMed MRCVS said: "It's important for vets to be aware of the importance of vaccinating rabbits against all 3 viral diseases: Myxomatosis, RVHD1 and RVHD2.
"We certainly don't want rabbits to go without their annual myxomatosis vaccine: this horrible disease is very much still around. RVHD1 appears to have been overtaken by the new variant, RVHD2, but should still be vaccinated against.
"RVHD2 is a recent strain of the RVHD virus, which the Nobivac Myxo-RHD vaccine does not cover, and it is, quite literally, everywhere. Transported by inanimate objects as well as animals, it can affect both indoor and outdoor rabbits anywhere in the UK.
"If you wait until you see the first case in your area before recommending vaccination, rabbits will die, when this could be avoided.
"Remember that rabbit owners are much more likely to bury their dead pets at home than cat and especially dog owners, who generally bring their pets to a vet for cremation, and so we, as a profession, are under-aware of the incidence of the disease out there.
"RVHD2 is a core vaccination requirement, being endemic in the UK. Additionally, it’s not just a fatal disease, it’s a fatal disease with a reservoir in the wild. We strongly recommend vaccination of rabbits with either Filavac or Eravac in addition to Nobivac Myxo-RHD."
For more information on this year’s campaign and to request your RAW veterinary pack with marketing materials and free samples, visit www.rabbitawarenessweek.co.uk
The course starts in October 2019 and lasts 12 months.
The programme is based around nine days of expert-led small group hands-on practical sessions at CPD Solutions' Training Centre near Birmingham, where participants will develop their existing dentistry skills and learn new techniques.
The company says decision-making is a key focus, as is reflective application of new skills in practice.
CPD Solutions says its PgCerts have unique benefits and differences from other options available, specifically that:
its courses have a stronger emphasis on practical training with all attendance sessions of a practical nature, and no lecture days.
its attendance days are grouped into three sessions rather than the more common monthly attendance.
its programme runs for 12 months, as opposed to many of the alternatives which run for 2-5 years.
Susie Coughlan, Managing Director at CPD Solutions, said: "Our experience is that vets get the most out of hands-on practical training in a structured and supportive environment, combined with reflective application of their new skills in practice.
"We set out to replicate this with the new PgCert in Small Animal Dentistry – all attendance sessions are practical, and the course provides support for developing reflective work-based learning that vets can then use throughout their careers. The format is in keeping with the RCVS CPD focus on outcomes based learning and critical reflective practice."
For more information, ring 0151 328 0444 or visit www.pgcertdent.com
The £11m project, which is backed by Mars Petcare, will include a cutting-edge imaging suite, state-of-the-art treatment facilities and a new linear accelerator.
Plans also include separate cat and dog waiting areas and client walking and comfort areas, seven operating theatres, 15 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and plans for a future hydrotherapy suite.
Daniel Hogan, operations manager at Southfields (pictured right), said: "This is a really exciting time for Southfields and our relocation will provide the region with one of the largest and best-equipped veterinary centres in the UK.
"The team and expertise have grown significantly in the past 18 months. We are very excited to continue to expand the unique and innovative offerings in patient care at our centre.
"Increasing in size will also enable us to provide a dedicated staff wellbeing area and an education centre and lecture hall, which will offer some very exciting qualifications and courses for the wider profession.
"Since our rebranding in 2017, we pride ourselves on leading the industry as a truly multidisciplinary centre with specialists from across the globe, including one of the most illustrious oncology teams in the country. Once this new site is launched, we will be able to offer an even more comprehensive service to our clients and patients."
For more information about Southfields, visit www.southfields.co.uk.
Six mixed-practice veterinary surgeons with over 200 combined years of experience have published a book of veterinary tips which they have collected from practising vets all over the UK in order to raise funds for VBF - the charity that supports veterinary professionals.
Alan Jeans, one of the authors, said: "The tips are ideas and techniques that we all use every day in practice but are the kind of thing that you only learn on the job. A range of vets from recent graduates through to veterinary teaching staff have checked the tips for suitability and, although many of the tips are aimed at new or recent graduates, vets of all ages and levels of experience will find plenty of very useful advice.
"The collection started as a 10-tip presentation on an annual CPD sailing trip in Turkey (pictured right) and grew from there. Throughout our careers we have all been impressed by the way that VBF has stepped in to help some of our colleagues in the profession through personal difficulties so we are delighted that we have found a way to fundraise for them."
Nick Short, VBF Director, said: "We are so grateful to all the authors listed in the book for their efforts on VBF's behalf. The tips can either be purchased as a complete collection in paperback by sending a suggested donation of £10 to VBF, 7 Mansfield Street, London W1G 9NQ or you can subscribe to receive regular e-tips on the Vetlife website at www.vetlife.org.uk.
We will also be taking pre-orders at BCVA Congress where VBF is going to be on the BCVA stand this year together with some of the veterinary surgeons who collected the tips.
Bradley Viner reviewed the book. He said: "I defy anyone, however long qualified, to honestly say that they did not learn something worthwhile from this little treasure of a book. And the cartoons are a great giggle as well!"
The book also received good reviews from two BVA Past Presidents. Peter Jinman said: "This little gem of a book is a distillate of the 'art' of veterinary medicine written by those who daily use the science for the benefit of animals under their care." Carl Padgett said: "A great little book. Easy to read and full of those tips that rarely make the covers of academic texts. Tricks old and new that help get the job done written by those that are doing the job."
The BVA has paid tribute to Lord Ballyedmond, founder of the veterinary pharmaceutical company Norbrook Laboratories, after he was killed in a helicopter crash in Norfolk last Thursday.
The life peer (pictured second from left collecting a business award in 2011) founded Norbrook over 40 years ago. It became one of the biggest manufacturers of animal health products globally, and now employs more than 1000 people. Dr. Edward Haughey, as he was previously known, was ennobled in 2004.
Following his death, Norbrook issued the following statement:
"It is with sincere sadness and deep regret that the Company confirms our founding Chairman and CEO, Lord Ballyedmond, was one of four people who tragically lost their lives in an aviation accident at Gillingham, Norfolk at approximately 7.30pm on Thursday 13 March 2014.
Norbrook management and staff also mourn the loss of their friends and colleagues Declan Small (Site Foreman), Captain Carl Dickerson (Pilot) and Captain Lee Hoyle (Pilot).
Our thoughts are with the immediate families and friends of the deceased who have requested privacy at this difficult time.
We take enormous pride in our Chairman's extraordinary legacy in establishing Norbrook as a global veterinary and pharmaceutical industry leader. Management will continue to advance his pioneering vision with a renewed vigor and determination befitting his memory."
BVA President Robin Hargreaves said: "We are deeply saddened to hear of the tragic passing of Lord Ballyedmond. He has been a great supporter of the veterinary profession and of BVA, and made an enormous contribution to veterinary medicine. He built opportunity for thousands of people in Northern Ireland and around the world and had a huge commercial and industrial presence throughout my whole career. Above all Lord Ballyedmond was a family man and all our thoughts are with his wife and children at this time."
In mid-September, the Association wrote to the RCVS expressing concern about the August extension to the temporary guidance.
In the latest update from the RCVS, the temporary measure has now been extended to 31 October but the flowchart and guidance have been updated to add some additional steps before a POM-V product can be prescribed remotely.
The BVA says that while it supported the original decision in March as a pragmatic solution and direct response to government restrictions surrounding Covid-19, it is now questioning the ongoing need for such a relaxation in the rules.
In the letter to the RCVS, the BVA also asked for a timeframe for the publication of the results of the RCVS survey of practices’ experiences of remote consulting and prescribing. The Association's own under care working group, chaired by Nigel Gibbens, has been developing a position to respond to the RCVS review.
BVA President James Russell (pictured right) said: "We understand that allowing remote prescription of POM-Vs was a necessary measure at the height of the lockdown, as practices struggled to assess patients in person.
"However, the veterinary professions have done a fantastic job in adapting to the restrictions and are now able to work safely and see patients.
"Whilst we recognise the RCVS has provided additional guidance for the remote prescribing of POM-V, we cannot currently see any reason why a new client would be unable to access in-person veterinary care in the first instance and we are asking RCVS Council to reconsider this measure when it meets in Oct.
"It makes sense to continue allowing vets to remotely prescribe for existing patients, for example if an owner is shielding, but we feel it is no longer appropriate to be remotely prescribing to animals that have never been physically examined by the vet.
“The question of whether we should be able to remotely prescribe POM-V products without first seeing an animal is an important and live debate, and we welcome the resumption of the College’s review. But the longer that temporary measures are in place, the greater the expectation from animal owners that they will always be in place, and the harder it will be to have the discussion about the best way forward.
“As a profession, we are rightly concerned about antimicrobial resistance and we pride ourselves on the responsible use of medicines. Continually extending the temporary measures without a full analysis would risk undermining our position.”
The definition agreed by VN Council is as follows:
Veterinary nursing aims to ease the suffering and pain of animals, and to improve their health and welfare.
This includes providing any medical treatment or any minor surgery (not involving entry into a body cavity) to animals under the direction of a veterinary surgeon who has that animal under their care.
Veterinary nursing can be either proactive or reactive, and autonomous or collaborative. It is carried out in a wide variety of settings, for animals at all life stages, and considers the background and needs of the animal’s owner or keeper.
Matthew Rendle RVN, the Chair of VN Council, said: “Although it is just a few short lines, this definition of veterinary nursing has been in the pipeline for some time.
"While we as veterinary nurses have always been able to define ourselves by the type of tasks we carry out, or our relation to veterinary surgeons in terms of delegation, there hasn’t necessarily been a clear statement articulating the art and science of veterinary nursing.
“With the RCVS looking to expand its regulatory remit to include other veterinary paraprofessionals over the long term, we thought it was particularly important that we set out the stall for veterinary nursing and we hope that this clear statement will, in particular, aid the public in understanding the role of a veterinary nurse.
“It should be noted that this definition is VN Council’s own considered interpretation of the art and science of veterinary nursing.
"Other interpretations from other organisations, provided they conform with both Schedule 3 of the Veterinary Surgeons Act and the RCVS Code of Professional Conduct, could sit comfortably alongside ours, and we hope there continues to be healthy discussion about the contribution of the profession to the veterinary team, as our role evolves.”
The model for the forecast was developed by the College with the Institute of Employment Studies using data from the RCVS Registers, the 2019 and 2024 Surveys of the Professions, Office for National Statistics data for projected economic growth and the PDSA’s Animal Wellbeing (PAW) Reports.
However, the model does not take account of the impact of the increasing costs of veterinary care on pet ownership trends, the full effect of which may not yet have been felt.
The main predictions of the model are:
Lizzie Lockett, RCVS Chief Executive Officer, said: “In 2021, there were clear concerns about there being a workforce crisis within the veterinary professions, and while that certainly seemed to be the case, and is likely to continue to be so in the short-term, according to this model the future picture for the professions looks much better in most areas of veterinary practice.
“However, government service/public health looks to be an area where there is still a significant shortfall in supply, which is concerning considering the importance of government vets in food safety, disease prevention and international trade and we are willing to continue to work with government to find ways to remedy this shortfall.
“We are aware that there may be some concerns about the implications of the model, particularly concerning the potential oversupply of veterinary nurses.
"While we stand by the robustness of the data, demography is not destiny, and with the planned enhancement of the veterinary nurse role, and the likelihood of suppressed demand due to prior shortages, it is likely that the number of veterinary nursing roles will expand to encompass the number of veterinary nurses available to work in it.
“Finally, we are aware that there are also some limitations to the model in its current form, for example, in terms of regional data.
"This is a work in progress, and we will continue to update and improve the model as and when new data allows.”
The workforce modelling report is available to download from www.rcvs.org.uk/publications
BCF has announced the launch of the Vita CR x-ray system from Carestream (formerly known as Kodak).
According to the company, the system provides high quality x-ray images, seamless integration into your existing workflow and improved productivity.
BCF says the Vita is ideal for practices looking for an affordable move from chemical to digital radiographic processing and offers:
Elly Pittaway, Veterinary Surgeon and Director at Broadlane Vets in Coventry said: "The Vita produces excellent quality images, is small, compact and really easy to use. It has changed things dramatically, especially for the nurses who no longer have to use nasty chemicals with wet processing. The vets find it easy to take x-rays so are encouraged to take more as it no longer takes the time it used to."
Kimberly Palgrave, the new in-house vet at BCF said: "At BCF, we understand that the ability to take high-quality x-rays quickly and accurately improves both clinical diagnostics and practice workflow. With the Vita x-ray system you can forget about the cost of purchasing and storing film and chemicals as well as health and safety issues associated with the handling and disposal of processor chemicals.
"Using the latest technology that the Vita offers you will reduce not only the number of repeated x-rays taken due to poor radiographic technique or processing faults, but also time spent performing routine equipment maintenance. This results in improved efficiency of your staff, saving you time and money. Faster image production may also enable a shorter duration of anaesthetic/ sedation to be used, improving patient care."
For more information, visit www.bcftechnology.com or ring BCF on 01506 460023.
Belfast-based Des Thompson MRCVS was presented with the first ever RCVS Queen's Medal by Her Majesty at Buckingham Palace this afternoon.
Des, pictured right showing off the new medal with his wife Rosalie, received two separate nominations for the medal, both citing his decades of active involvement in veterinary politics which includes being president of the RCVS, the British Small Animal Veterinary Association (BSAVA), the Society of Practising Veterinary Surgeons (SPVS) and the Northern Ireland Veterinary Association, among other organisations.
Also cited was his willingness to help other members of the profession, particularly young vets at the beginning of their careers, through his involvement with organisations such as the Young Vet Network in Northern Ireland and the Veterinary Benevolent Fund.
The Queen's Medal was launched in 2013, with the approval of Her Majesty as Patron of the RCVS, and is now the highest award that can be bestowed upon a veterinary surgeon in recognition of a particularly outstanding contribution to the profession. In receiving the medal, Des was joined by Professor Stuart Reid, current RCVS President, Colonel Neil Smith, immediate past President, and Gordon Hockey, RCVS Registrar.
Des said: "It was a complete honour and a wonderful experience to be received by Her Majesty at Buckingham Palace today, and I'm thrilled to have been awarded the RCVS Queen's Medal. Her Majesty was interested to hear about Northern Ireland, and the fact that I've been practising there since I qualified."
Barrettine Environmental Health has launched MiteMax, a new treatment for poultry red mite (PRM) with a physical mode of action.
Charles Phillips from Barratine said: "PRM poses a significant threat to laying hens particularly, with infestation costing the UK egg industry in excess of an estimated €3 million per annum through PRM control and lost production. In the UK, PRM is prevalent in varying percentages according to the rearing system used. Caged birds are estimated to have a variable 7.5 to 87.5 % prevalence. Free range systems are estimated to have 60 % prevalence of PRM, with organic systems higher at 78 %. Less intensive systems have a greater prevalence of PRM due to the higher number of cracks and crevices associated with a more enriched environment1."
MiteMax is applied directly to a shed’s inner surfaces via knapsack sprayer, rendering the surfaces sticky and permanently immobilising red mites that come into contact with them.
According to the company, the new product - which is designed to fit into and encourage integrated pest management practices - provides rapid knock-down of poultry red mite.
Charles added: "The physical mode of action of MiteMax makes it effective against pesticide-resistant mites. MiteMax is specifically formulated to penetrate surface dust making it highly effective at reaching mites harbouring deep in crevices."
In conjunction with robust cleansing practices, Ian Whelan an expert in physical insect control techniques says MiteMax fits neatly into an integrated pest management style of husbandry: "Using treatments with different modes of action together as part of a flock health plan ensures each one fulfils its potential."
MiteMax is available nationwide from Barrettine Environmental Health's appointed distributors.
Dechra says necrotic enteritis can be treated with a variety of therapeutic antibiotics but that the first choice antibiotics¹ for treatment are narrow spectrum antibiotics, like phenoxymethylpenicillin.
Phenocillin is an 800 mg/g powder for use in drinking water. It is lactose free, and Dechra says its high solubility makes it ideal for concentrated stock solutions and convenient for modern poultry farming. There is a zero withdrawal time so egg production is unaffected.
Dechra Brand Manager Emma Jennings said: “Necrotic enteritis is the most common bacterial disease in modern broiler flocks that can be financially devastating for farmers.
"The high concentration means easy dosage and handling with less waste and the lactose free formula reduces the risk of biofilm development resulting in a high quality and effective product, supporting the responsible use of antimicrobials.
"Phenocillin is a highly effective treatment and we anticipate it will become the preferred solution for veterinary professionals and end users to treat this disease that can very suddenly devastate broiler flocks."
For more information, visit: http://bit.ly/2nAboGU
All vets are encouraged to take part, and everyone who does will get a copy of the results.
The survey covers small animal, large animal and equine in all aspects of preventative health care and surgery.
It also looks at repeat prescription charges, the routine use of analgesia and antibiotics in neutering and lab interpretation fees, comparing them to last year.
https://surveys.spvs.org.uk
Vets Now Referrals has launched a new specialist veterinary referral service to serve Aberdeen and the North.
Richard Coe MA VetMB CertSAS DipECVS MRCVS (pictured right) and Professor Stuart Carmichael BVMS MVM DSAO MRCVS will attend Ardene House Veterinary Hospital in Aberdeen on a monthly rotational basis to offer specialist care to pets from the area. Richard is a European Specialist in Small Animal Surgery and Professor Carmichael is an internationally recognised expert in veterinary orthopaedics.
By bringing these two specialist surgeons to Aberdeen, it will mean that vets can refer their clients to have their initial consultations and diagnoses locally by either Richard or Stuart, reducing the need for a lengthy journey to Vets Now Referrals in Glasgow where they are usually based. Vets Now says that where possible, treatment plans will be carried out in Aberdeen, however complex treatments may require the facilities and high tech equipment at its Glasgow Hospital.
Any vet wishing to make an enquiry about referring to Richard or Stuart should call 01224 478 041. Further information about the service can also be found on www.vetsnowreferrals.com/aberdeen.
Tricia Colville, Hospital Manager of Vets Now Referrals, Glasgow, said: "We are delighted to now be able to offer our specialist service for vets in the North of Scotland to utilise for their clients. The Vets Now Referrals Hospital in Glasgow has been so successful since it opened over a year ago, benefiting hundreds of pets and their owners. Bringing the service to Aberdeen and the surrounding region will provide vets with local access to Richard Coe and Professor Stuart Carmichael who are both renowned in their fields and for their clients this provides a convenient option which will greatly reduce time-consuming, distressing and costly journeys for them."
As part of the partnership between the two companies, anyone who takes part in one of Improve's CPD courses in 2018 will be entitled to 6 months' half-price pet insurance from Agria.
Online Bitesize CPD modules cover topics including: cardiology, ophthalmology, small animal medicine, feline medicine and exotic animals. Modules are 20, 40 or 60 minutes in length and provide veterinary professionals with interactive experiences which count toward annual CPD requirements in short convenient bursts, earning digital badges and certificates to demonstrate total CPD achieved.
Nick White, Head of Veterinary Channel at Agria, said: "We’re delighted that our partnership with Improve International will give veterinary professionals free, instant access to high-quality and engaging CPD. Not only are the modules available varied and highly relevant, the 'bitesize' nature of the training makes it extremely convenient for busy practice staff to access.
"This is a great incentive for any practices not yet working with Agria to get onboard. As well as benefitting from free CPD, practices will also be working with a specialist lifetime insurer offering 5 weeks free insurance policies and much more for clients and their pets."
For more information, contact your Agria Business Development Manager or visit: www.agriapet.co.uk/bitesize and complete the Contact Us section, using 'FREE CPD' in the subject line of the enquiry box.
Researchers and practitioners working in any field of academia, industry and/or clinical practice are invited to apply for an award of up to £2,000 to fund a research project relevant to the aims of the VMG, which represents veterinary professionals working in leadership and management roles.
The VMG says it has launched the scheme to help veterinary leaders embrace the challenges and opportunities faced by the sector and to help them to continue to meet patient needs effectively while remaining profitable.
VMG Junior Vice President Mr Richard Casey said: "Business landscapes are changing and the veterinary world is no exception. The VMG is ideally placed not only to support our members but also to help the wider profession. We hope that our grant scheme will support research that enhances our understanding of contemporary veterinary business, leadership and management and helps us to develop a solid evidence base for best practice. We are looking forward to receiving some exciting proposals."
Further information, including the Stage 1 application form and guidance notes, are available here: https://www.vetmg.com/vmg-research-awards/
The deadline for applications is 19 July 2019.
The deal is expected to complete by the middle of 2020.
According to the terms of the deal, Vetoquinol will acquire the Profender and Drontal product families, the intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business.
Jeff Simmons, president and CEO of Elanco said: "We’re pleased with the continued progress on a number of fronts to move the acquisition of Bayer AG’s animal health business toward completion.
Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire the Profender and Drontal product lines that are highly valued by veterinarians and pet owners. The acquisition of these two strong brands is at the heart of our strategy. On the one hand, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. On the other hand, they will strengthen our portfolio of Essentials, the engine of our growth."